6 completed, 4 recruiting, 2 terminated, 2 unknown. 15 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 15 | Completed 6, Recruiting 4, Terminated 2, Unknown 2, Withdrawn 1 |
Follow contrast agent BR1: new trials by email Literature Review of contrast agent BR1 trials Research Report on contrast agent BR1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion Addition of ultrasound with contrast injection (SonoVue®), Standard Care (in control arm) - Adnexal Torsion | Phase 3 | Recruiting | Central Hospital, Nancy, France | 256 | 2025-05-14 | 2026-04-08 |
| Study of Placental Vascularization Using Contrast Ultrasound SonoVue - Fetal Growth Restriction | Phase 3 | Recruiting | Central Hospital, Nancy, France | 30 | 2025-04-09 | 2026-04-07 |
| A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients Bevacizumab, Microbubble, Low-Intensity Focused Ultrasound - Glioblastoma Multiforme, Glioblastoma | Phase 3 | Recruiting | NaviFUS Corporation | 32 | 2024-11-08 | 2026-04-09 |
| Neonatal Brain Ultrasound With CEUS and Elastography Brain contrast enhanced ultrasound, brain ultrasound elastography, Sulfur Hexafluoride - Neonatal Hypoxic Ischemic Encephalopathy, Neonatal Stroke | Phase 3 | Recruiting | Turku University Hospital | 100 | 2024-01-01 | 2026-01-15 |
| Preterm Neonates Brain Ultrasound With CEUS and Elastography Brain contrast enhanced ultrasound, brain ultrasound elastography, Sulfur Hexafluoride - Prematurity | Phase 3 | Withdrawn | Turku University Hospital | 2024-01-01 | 2026-01-15 | |
| Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC Sonovue and Sonazoid, Sonazoid and Sonovue - Hepatocellular Carcinoma, Cirrhosis | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 100 | 2019-06-30 | 2019-09-19 |
| Contrast Enhanced Sonothrombolysis and Sonolysis in Stroke - a Swedish Study (CE-5S) SonoVue, Sodium chloride, Transcranial Ultrasound - Ischemic Stroke | Phase 3 | Terminated | Umeå University | 1 | 2017-11-28 | 2018-05-11 |
| KVUS at Neoadjuvant CTx of Breast Cancer SonoVue - Early Primary Breast Cancer | Phase 3 | Unknown | RWTH Aachen University | 60 | 2016-12-12 | 2017-12-28 |
| HexafluOride, a Contrast Agent for Placenta Echo-angiography Contrast agent: SonoVue®. - Pregnancy | Phase 3 | Completed | Centre Hospitalier Régional Metz-Thionville | 55 | 2016-10-12 | 2026-06-24 |
| Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142 Lumason - Coronary Artery Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 174 | 2015-10-12 | 2021-07-07 |
| Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography sulphur hexafluoride lipid-type A microspheres - Heart Disease | Phase 3 | Terminated | Bracco Diagnostics, Inc | 13 | 2015-10-01 | 2020-07-13 |
| Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-141 Lumason - Coronary Artery Disease | Phase 3 | Completed | Bracco Diagnostics, Inc | 175 | 2015-09-24 | 2021-06-11 |
| An Efficacy and Safety Study of Sonazoid™ and SonoVue® in Participants With Focal Liver Lesions, Undergoing Pre- and Post-Contrast Ultrasound Imaging Sonazoid™, SonoVue® - Liver Lesions | Phase 3 | Completed | GE Healthcare | 424 | 2014-05-11 | 2018-10-31 |
| IMaging Della PLAcca Carotidea Visipaque 320 and SonoVue - Carotid Artery Plaque, Atherosclerosis | Phase 3 | Completed | Enrico Ammirati | 75 | 2012-04-01 | 2018-02-19 |
| SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization SonoVue® - Liver Neoplasms | Phase 3 | Completed | Bracco Diagnostics, Inc | 353 | 2010-06-01 | 2018-08-03 |
Coronary Artery Disease (2) · Ischemic Stroke (2) · Atherosclerosis (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carotid Artery Diseases (1) · Carotid Stenosis (1) · Fetal Growth Retardation (1) · Fibrosis (1) · Glioblastoma (1) · Glioma (1) · Heart Diseases (1) · Liver Neoplasms (1) · Neoplasms (1)
Bracco Diagnostics, Inc (4) · Central Hospital, Nancy, France (2) · Turku University Hospital (2) · Centre Hospitalier Régional Metz-Thionville (1) · Enrico Ammirati (1) · GE Healthcare (1) · NaviFUS Corporation (1) · RWTH Aachen University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Umeå University (1)
United States (4) · France (3) · Canada (2) · China (2) · Finland (2) · Germany (2) · Taiwan (2) · Belgium (1) · Italy (1) · South Korea (1) · Sweden (1) · United Kingdom (1)
Jussi Hirvonen (2) · Melda Dolan, MD (2) · Riitta Parkkola (2) · Tiina Laurikainen (2) · Vilhelmiina Parikka (2) · Alberto Spinazzi, M.D. (1) · Elias Johansson, MD, PhD (1) · Elmar Stickeler, niv.-Prof. Dr. med. (1) · Enrico Ammirati, Doctor (1) · Francois Tranquart, MD, PhD (1) · Melda Dolan, M.D. (1) · Paolo G Camici, Professor (1)
PMID 26777226, PMID 27751505, PMID 28874779, PMID 29432486, PMID 31101367, PMID 31511289, PMID 38401206
2023 (1)